Epidural Fentanyl for 2nd Stage Labor Analgesia
Primary Purpose
Labor Pain
Status
Recruiting
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Fentanyl 20 mcg
Fentanyl 100 mcg
Sponsored by
About this trial
This is an interventional prevention trial for Labor Pain
Eligibility Criteria
Inclusion Criteria:
- Nulliparous women
- Spontaneous labor
- A single vertex presentation fetus at term (38-42 weeks)
- Effective labor epidural analgesia with continuous epidural infusion established
- Provide written consent to participate in the study.
Exclusion Criteria:
- Multigravida women
- Multigestation pregnancies
- Patients being treated/managed for chronic pain
- Allergies or significant adverse reactions to local anesthetic or opioid medications
- Inadequate or unsatisfactory labor epidural analgesia
- Patients with history of spine abnormalities or spine surgery
- Non-English speaking
- Prisoners
- Age less than 18 years old
Sites / Locations
- The Ohio State University Wexner Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Low Dose Fentanyl
High Dose Fentanyl
Arm Description
Low dose epidural fentanyl combined with local anesthetic as 10mL of 0.125% bupivacaine with 20 mcg fentanyl (Fentanyl 20 mcg)
High dose epidural fentanyl combined with local anesthetic as 10mL of 0.125% bupivacaine with 100 mcg fentanyl (Fentanyl 100 mcg)
Outcomes
Primary Outcome Measures
VRS Pain Score
VRS Pain score
Secondary Outcome Measures
VRS Pain Score
VRS Pain Score
Mode of Delivery
Mode of Delivery (cesarean, spontaneous vaginal or assisted vaginal delivery)
Patient Satisfaction
Patient Satisfaction with Labor Pain Control (1-100 rating scale; 1= not satisfied at all, 100=completely satisfied)
Adverse Events
Nausea, vomiting, shivering, pruritis, hypotension, motor block, maternal respiratory depression, neonatal outcomes
Rescue Epidural Boluses
Total number of clinician administered epidural boluses during the late first (≥8cm cervical dilation) and second stages of labor
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03120780
Brief Title
Epidural Fentanyl for 2nd Stage Labor Analgesia
Official Title
High Dose Epidural Fentanyl for Second Stage Labor Analgesia
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 26, 2017 (Actual)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ohio State University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study is being done to investigate if there is more effective pain relief during the latter stages of labor and delivery when epidural fentanyl 100mcg is administered compared to epidural fentanyl 20mcg.
Detailed Description
The objective is to evaluate if high-dose epidural fentanyl (100 micrograms) is more effective at providing pain relief during the late first stage (>8 cm cervical dilation) and second stage of labor until the time of delivery compared to low-dose epidural fentanyl (20 micrograms). In this study, anesthetic care will be provided to a subject by an experienced anesthesia provider according to standard hospital care. If the subject has adequate pain relief from the continuous epidural infusion, then a study investigator will record the verbal pain score and document any other side effects at hourly intervals beginning at >8cm cervical dilation, but no additional epidural medications will be administered. If pain relief becomes inadequate during the late first or second stage of labor (>8cm cervical dilation) and a manual epidural bolus is required, then the subject will be randomly assigned to one of two groups (like flipping a coin): one group will receive lower dose epidural fentanyl (20 micrograms) combined with local anesthetic; and one group will receive higher-dose epidural fentanyl (100micrograms) combined with the same amount of local anesthetic. Both doses are used frequently on labor and delivery and are considered to be safe based on available evidence. If there is not sufficient pain relief from the epidural medication given, then an experienced anesthesia provider will assess if another epidural dose may be effective and this additional epidural medication will be given at the discretion of the anesthesia provider. An experienced anesthesia provider will be available at all times during the study to assess pain and provide epidural medications. All patients participating in the study will have their pain scores assessed every hour as soon as the cervical dilation is noted to be >8cm; at the time of randomization; and at 10, 20, 30 and 60 minutes after the epidural dose is administered. The presence of any side-effects such as itching, shivering, nausea, vomiting, low blood pressure, slow respiratory rate or lower extremity muscle weakness will also be collected at hourly intervals as soon as the cervical dilation is noted to be >8cm. Subject satisfaction (1-100 rating scale) with anesthetic care provided will be assessed on postpartum day # 1 during routine follow-up visit.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Labor Pain
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
Subjects will be randomly assigned to one of two groups: one group will receive lower dose epidural fentanyl (20 micrograms) combined with local anesthetic; and one group will receive higher-dose epidural fentanyl (100micrograms) combined with the same amount of local anesthetic.
Masking
Participant
Masking Description
The subject and the research personnel will be blinded to the arm to which they are randomized. Only the clinician assessing the patient and administering epidural doses will be not be blinded to the study group.
Allocation
Randomized
Enrollment
150 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Low Dose Fentanyl
Arm Type
Active Comparator
Arm Description
Low dose epidural fentanyl combined with local anesthetic as 10mL of 0.125% bupivacaine with 20 mcg fentanyl (Fentanyl 20 mcg)
Arm Title
High Dose Fentanyl
Arm Type
Experimental
Arm Description
High dose epidural fentanyl combined with local anesthetic as 10mL of 0.125% bupivacaine with 100 mcg fentanyl (Fentanyl 100 mcg)
Intervention Type
Drug
Intervention Name(s)
Fentanyl 20 mcg
Other Intervention Name(s)
Low Dose
Intervention Description
20 mcg fentanyl in 10 mL 0.125% bupivacaine
Intervention Type
Drug
Intervention Name(s)
Fentanyl 100 mcg
Other Intervention Name(s)
High Dose
Intervention Description
100 mcg fentanyl in 10 mL 0.125% bupivacaine
Primary Outcome Measure Information:
Title
VRS Pain Score
Description
VRS Pain score
Time Frame
30 minutes after epidural bolus
Secondary Outcome Measure Information:
Title
VRS Pain Score
Description
VRS Pain Score
Time Frame
At Time of Delivery
Title
Mode of Delivery
Description
Mode of Delivery (cesarean, spontaneous vaginal or assisted vaginal delivery)
Time Frame
At Time of Delivery
Title
Patient Satisfaction
Description
Patient Satisfaction with Labor Pain Control (1-100 rating scale; 1= not satisfied at all, 100=completely satisfied)
Time Frame
During labor until post-partum day one
Title
Adverse Events
Description
Nausea, vomiting, shivering, pruritis, hypotension, motor block, maternal respiratory depression, neonatal outcomes
Time Frame
During labor until post-partum day one
Title
Rescue Epidural Boluses
Description
Total number of clinician administered epidural boluses during the late first (≥8cm cervical dilation) and second stages of labor
Time Frame
Until delivery
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Must be pregnant woman to considered for study.
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Nulliparous women
Spontaneous labor
A single vertex presentation fetus at term (38-42 weeks)
Effective labor epidural analgesia with continuous epidural infusion established
Provide written consent to participate in the study.
Exclusion Criteria:
Multigravida women
Multigestation pregnancies
Patients being treated/managed for chronic pain
Allergies or significant adverse reactions to local anesthetic or opioid medications
Inadequate or unsatisfactory labor epidural analgesia
Patients with history of spine abnormalities or spine surgery
Non-English speaking
Prisoners
Age less than 18 years old
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
John Coffman, MD
Phone
614-293-8487
Email
john.coffman@osumc.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Juan Fiorda, MD
Phone
614-293-3559
Email
juan.fiorda@osumc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Coffman, MD
Organizational Affiliation
The Ohio State University Wexner Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Ohio State University Wexner Medical Center
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43210
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
John Coffman, MD
Phone
614-293-8497
Email
john.coffman@osumc.edu
First Name & Middle Initial & Last Name & Degree
Juan Fiorda, MD
Phone
614-293-3559
Email
juan.fiorda@osumc.edu
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
No plan to share IPD.
Learn more about this trial
Epidural Fentanyl for 2nd Stage Labor Analgesia
We'll reach out to this number within 24 hrs